Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The Publications section was updated to include the 2024 Blood article by Friedberg et al. on frontline brentuximab vedotin therapy for older HL patients ineligible for chemotherapy, and the Erratum for that Blood article was removed.
    Difference
    0.0%
    Check dated 2026-04-02T15:35:03.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page; this appears to be a maintenance/versioning update with no changes to study content.
    Difference
    0.0%
    Check dated 2026-03-19T04:59:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3 instead of Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:49:36.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The Blood 2024 publication citation Friedberg et al. was added and subsequently removed from the Publications section.
    Difference
    0.0%
    Check dated 2026-03-04T23:51:58.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. The notice about lapse in government funding was removed.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:06.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.